Table 1. Bivariate analysis of the characteristics of the patients who achieved serological cure.
Characterstic | Serological cure (n = 870) | Serofast (n = 457) | OR | OR(95% CI) | |
Low | Upper | ||||
Gender | |||||
Female | 312 | 233 | 1 | ||
Male | 558 | 224 | 1.860 | 1.478 | 2.341 |
Age | |||||
<23 | 57 | 13 | 2.023 | 1.080 | 3.790 |
23–29 | 144 | 113 | 0.588 | 0.434 | 0.796 |
30–40 | 281 | 152 | 0.853 | 0.654 | 1.112 |
>40 | 388 | 179 | 1 | ||
Baseline RPR Titer | |||||
1∶1 | 310 | 77 | 2.984 | 1.979 | 4.498 |
1∶2 | 171 | 73 | 1.736 | 1.134 | 2.658 |
1∶4 | 77 | 61 | 0.936 | 0.586 | 1.494 |
1∶8 | 55 | 57 | 0.715 | 0.437 | 1.171 |
1∶16 | 77 | 73 | 0.782 | 0.495 | 1.234 |
1∶32 | 95 | 53 | 1.329 | 0.832 | 2.122 |
≥1∶64 | 85 | 63 | 1 | ||
Phase | |||||
Primary | 250 | 42 | 1 | ||
Secondary | 231 | 129 | 0.298 | 0.195 | 0.453 |
Tertiary | 140 | 119 | 0.196 | 0.126 | 0.305 |
Latent | 249 | 167 | 0.247 | 0.161 | 0.381 |
Abbreviations: OR, odds ratios; CI, confidence interval.